Kymera Therapeutics, Inc. Common Stock (KYMR) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KYMR. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price | 13,370,241 | $1.5B | INCREASED |
| FMR | 12,349,256 | $1.4B | INCREASED |
| Baker Bros. Advisors | 8,657,242 | $993M | UNCHANGED |
| Avoro Capital Advisors | 7,474,747 | $857M | UNCHANGED |
| Vanguard | 6,467,324 | $742M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Brian Adams (Chief Legal Officer) | SELL | 2,137 | $251K | 2026-09-04 |
| Brian Adams (Chief Legal Officer) | SELL | 3,025 | $353K | 2026-09-04 |
| Brian Adams (Chief Legal Officer) | SELL | 1,209 | $140K | 2026-09-04 |
| Terence Rooney (Chief Medical Officer) | AWARD | 76,000 | $8M | 2026-07-27 |
| Terence Rooney (Chief Medical Officer) | AWARD | 38,000 | 2026-07-27 |
Full institutional holdings, insider history, and congressional trades for Kymera Therapeutics, Inc. Common Stock on SentiSense.